Table 1.
Characteristics of all patients and in the groups.
| All Patients (n = 836) |
Standard Group (n = 422) |
Copeptin Group (n = 414) |
|
|---|---|---|---|
| Patients’ characteristics | |||
| Age (years) (mean ± SD) | 53.3 ± 15.4 | 53.2 ± 14.9 | 53.4 ± 16.0 |
| Male sex | 62.0 (518) | 64.2 (271) | 59.7 (247) |
| Risk factors | |||
| BMI | 27.3 ± 4.79 | 27.3 ± 4.56 | 27.2 ± 5.00 |
| Diabetes | 12.9 (107) | 13.2 (55) | 12.6 (52) |
| Hypertension | 56.8 (469) | 56.7 (236) | 56.8 (233) |
| Hyperlipidaemia | 43.6 (354) | 45.1 (184) | 42.1 (170) |
| Family history of MI | 27.4 (214) | 24.5 (95) | 30.4 (119) ** |
| Smoker | 33.2 (270) | 35.1 (144) | 31.2 (126) |
| Ex-smoker | 31.1 (253) | 29.8 (122) | 32.4 (131) |
| GRACE-score (mean ± SD) | 78.76 ± 26.7 | 78.12 ± 26.4 | 79.42 ± 27.1 |
| TIMI risk score (Median/IQR) | 1 (0–2) | 1 (0–2) | 1 (0–2) |
| Medical history | |||
| Known CAD | 25.2 (207) | 24.5 (101) | 26.0 (106) |
| Prior MI | 13.3 (110) | 14.4 (60) | 12.2 (50) |
| Prior PCI | 21.3 (176) | 21.3 (88) | 21.4 (88) |
| Prior CABG | 4.3 (36) | 3.1 (13) | 5.6 (23) ** |
| Chronic heart failure | 5.6 (46) | 3.9 (16) | 7.4 (30) * |
| Primary valve disease | 7.0 (57) | 7.1 (29) | 6.9 (28) |
| Prior valve surgery | 1.2 (10) | 1.0 (4) | 1.5 (6) |
| Cardiomyopathy | 1.8 (15) | 0.5 (2) | 3.2 (13) * |
| Renal disease | 4.9 (40) | 3.6 (15) | 6.1 (25) |
| Time since symptom onset | |||
| 0–3 h (less or equal 3) | 35.2 (294) | 36.7 (155) | 33.6 (139) |
| <6 h | 42.5 (355) | 44.1 (186) | 40.8 (169) |
| <12 h | 52.3 (437) | 51.9 (219) | 52.7 (218) |
| unknown | 170 | 79 | 91 |
BMI, body mass index; TIMI, thrombolysis in myocardial infarction; CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft. Continuous variables are given as means with standard deviation. Discrete variables are reported as relative frequencies with absolute numbers in brackets. * p-value < 0.05, ** p-value < 0.01.